Petričević, Saša

Link to this page

Authority KeyName Variants
a853cf25-0fcd-44b6-bb2f-a6710510ab62
  • Petričević, Saša (5)
Projects

Author's Bibliography

Beneficial effects of probiotic supplementation on glucose and triglycerides in a mouse model of metabolic syndrome

Zavišić, Gordana; Ristić, Slavica; Rikalović, Milena; Petković, Branka; Janković, Drina; Vukadinović, Aleksandar; Petričević, Saša

(Amsterdam: Elsevier, 2022)

TY  - JOUR
AU  - Zavišić, Gordana
AU  - Ristić, Slavica
AU  - Rikalović, Milena
AU  - Petković, Branka
AU  - Janković, Drina
AU  - Vukadinović, Aleksandar
AU  - Petričević, Saša
PY  - 2022
UR  - https://linkinghub.elsevier.com/retrieve/pii/S1756464622002377
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/5091
AB  - The present study aimed to examine the effect of Lactobacillus rhamnosus Rosell 11 and Lactobacillus helveticus Rosell 52 on glucose (blood level and tolerance), lipids (cholesterol and triglycerides), transaminases (AST and ALT), ALP, urea, and creatinine, along with body weight, food intake, liquid consumption, and gross pathology in a mouse model of metabolic syndrome. Male C57BL/6J mice were fed a high-fat high-sucrose diet and treated by oral gavage with a probiotic mixture in three different concentrations (107, 108, and 109 CFU/mL) once daily for 2 months. Probiotic supplementation, particularly at a concentration of 109 CFU, significantly decreased blood glucose and serum triglyceride levels, improved glucose tolerance, and promoted body weight loss in mice fed a high-fat high-sucrose diet. According to the obtained results, probiotic supplementation is useful for controlling glucose and triglyceride levels and could be used as an adjunctive therapeutic approach in patients with metabolic syndrome. © 2022
PB  - Amsterdam: Elsevier
T2  - Journal of Functional Foods
T1  - Beneficial effects of probiotic supplementation on glucose and triglycerides in a mouse model of metabolic syndrome
VL  - 95
DO  - 10.1016/j.jff.2022.105167
SP  - 105167
ER  - 
@article{
author = "Zavišić, Gordana and Ristić, Slavica and Rikalović, Milena and Petković, Branka and Janković, Drina and Vukadinović, Aleksandar and Petričević, Saša",
year = "2022",
abstract = "The present study aimed to examine the effect of Lactobacillus rhamnosus Rosell 11 and Lactobacillus helveticus Rosell 52 on glucose (blood level and tolerance), lipids (cholesterol and triglycerides), transaminases (AST and ALT), ALP, urea, and creatinine, along with body weight, food intake, liquid consumption, and gross pathology in a mouse model of metabolic syndrome. Male C57BL/6J mice were fed a high-fat high-sucrose diet and treated by oral gavage with a probiotic mixture in three different concentrations (107, 108, and 109 CFU/mL) once daily for 2 months. Probiotic supplementation, particularly at a concentration of 109 CFU, significantly decreased blood glucose and serum triglyceride levels, improved glucose tolerance, and promoted body weight loss in mice fed a high-fat high-sucrose diet. According to the obtained results, probiotic supplementation is useful for controlling glucose and triglyceride levels and could be used as an adjunctive therapeutic approach in patients with metabolic syndrome. © 2022",
publisher = "Amsterdam: Elsevier",
journal = "Journal of Functional Foods",
title = "Beneficial effects of probiotic supplementation on glucose and triglycerides in a mouse model of metabolic syndrome",
volume = "95",
doi = "10.1016/j.jff.2022.105167",
pages = "105167"
}
Zavišić, G., Ristić, S., Rikalović, M., Petković, B., Janković, D., Vukadinović, A.,& Petričević, S.. (2022). Beneficial effects of probiotic supplementation on glucose and triglycerides in a mouse model of metabolic syndrome. in Journal of Functional Foods
Amsterdam: Elsevier., 95, 105167.
https://doi.org/10.1016/j.jff.2022.105167
Zavišić G, Ristić S, Rikalović M, Petković B, Janković D, Vukadinović A, Petričević S. Beneficial effects of probiotic supplementation on glucose and triglycerides in a mouse model of metabolic syndrome. in Journal of Functional Foods. 2022;95:105167.
doi:10.1016/j.jff.2022.105167 .
Zavišić, Gordana, Ristić, Slavica, Rikalović, Milena, Petković, Branka, Janković, Drina, Vukadinović, Aleksandar, Petričević, Saša, "Beneficial effects of probiotic supplementation on glucose and triglycerides in a mouse model of metabolic syndrome" in Journal of Functional Foods, 95 (2022):105167,
https://doi.org/10.1016/j.jff.2022.105167 . .
1
4
2

Dual role of mitochondrial damage in anticancer and antipsychotic treatment

Misirkić Marjanović, Maja; Vučićević, Ljubica; Kosić, Milica; Paunović, Verica; Arsikin-Csordas, Katarina; Ristić, Biljana; Marić, Nađa; Bošnjak, Mihajlo; Zogović, Nevena; Mandić, Miloš; Kravić-Stevović, Tamara; Martinović, Tamara; Ćirić, Darko; Mirčić, Aleksandar; Petričević, Saša; Bumbaširević, Vladimir; Harhaji-Trajković, Ljubica; Trajković, Vladimir

(The Mitochondrial Physiology Society, 2019)

TY  - CONF
AU  - Misirkić Marjanović, Maja
AU  - Vučićević, Ljubica
AU  - Kosić, Milica
AU  - Paunović, Verica
AU  - Arsikin-Csordas, Katarina
AU  - Ristić, Biljana
AU  - Marić, Nađa
AU  - Bošnjak, Mihajlo
AU  - Zogović, Nevena
AU  - Mandić, Miloš
AU  - Kravić-Stevović, Tamara
AU  - Martinović, Tamara
AU  - Ćirić, Darko
AU  - Mirčić, Aleksandar
AU  - Petričević, Saša
AU  - Bumbaširević, Vladimir
AU  - Harhaji-Trajković, Ljubica
AU  - Trajković, Vladimir
PY  - 2019
UR  - https://www.mitoeagle.org/index.php/MiP2019/MitoEAGLE_Belgrade_RS
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/6353
AB  - We analyzed the impact of mitochondrial damage in anticancer action of combining lysosomal
membrane permeabilization (LMP)-inducing agent N- dodecylimidazole (NDI)[1] with
glycolytic inhibitor 2-deoxy-D-glucose (2DG) and in antipsychotic action of atypical antipsychotic
olanzapine.
NDI-triggered LMP and 2DG-mediated glycolysis block synergized in inducing ATP depletion,
mitochondrial damage and reactive oxygen species production, eventually leading to necrotic
death of U251 glioma cells but not primary astrocytes. NDI/2DG-induced death of glioma
cells was partly prevented by lysosomal cathepsin inhibitor E64 and antioxidant tocopherol, suggesting
the involvement of LMP and oxidative stress in the observed cytotoxicity. Moreover, the
combined oral administration of NDI and 2DG reduced in vivo melanoma growth in C57BL/6
mice by inducing necrotic death of tumor cells.
Based on these results, we propose that NDI-triggered LMPcauses initial mitochondrial damage
that is further increased by 2DG due to the lack of glycolytic ATP required to maintain mitochondrial
health. This leads to a positive feedback cycle of mitochondrial dysfunction, ATP loss,
and reactive oxygen species production, culminating in necrotic cell death.
We also investigated the role of autophagy, a controlled cellular self-digestion process, in regulating
survival of neurons exposed to olanzapine. Olanzapine induced autophagy in human
SH-SY5Y neuronal cell line, as confirmed by the increase in autophagic flux and presence of
autophagic vesicles, fusion of autophagosomes with lysosomes, and increase in the expression
of autophagy-related (ATG) genes ATG4B, ATG5, andATG7. The production of reactive oxygen
species, but not modulation of the main autophagy repressor mTOR or its upstream regulators
AMP-activated protein kinase and AKT1, was responsible for olanzapine-triggered autophagy.
Olanzapine-mediated oxidative stress also induced mitochondrial depolarization and damage,
and the autophagic clearance of dysfunctional mitochondria [2] was confirmed by electron microscopy,
colocalization of autophagosome associated MAP1LC3B (LC3B) and mitochondria,
and mitochondrial association with the autophagic cargo receptor p62. While olanzapine-triggered
mitochondrial damage was not visibly toxic to SH-SY5Ycells, their death was readily initiated
upon the inhibition of autophagy with pharmacological inhibitors, RNA interference knockdown
of BECN1 and LC3B. The treatment of mice with olanzapine increased the brain levels of
LC3B-II and mRNA encoding Atg4b,Atg5, Atg7, Atg12, Gabarap, and Becn1.
These data indicate that olanzapine-triggered autophagy protects neurons from otherwise fatal
mitochondrial damage, and that inhibition of autophagy might unmask the neurotoxic action
of the drug.
References;
1. Repnik U, Turk B (2010) Lysosomal-mitochondrial cross-talk during cell death.
Mitochondrion10: 662-669.
2. Wang K, Klionsky DJ(2011) Mitochondrial removal by autophagy. Autophagy 7:297-300.
PB  - The Mitochondrial Physiology Society
C3  - Programme abstract book: 14th Conference on Mitochondrial Physiology: Mitochondrial function: changes during life cycle and in noncommunicable diseases: COST MitoEAGLE perspectives and MitoEAGLE WG and MC Meeting: MiP2019/MitoEAGLE; 2019 Oct 13-16; Belgrade, Serbia
T1  - Dual role of mitochondrial damage in anticancer and antipsychotic treatment
SP  - 29
EP  - 29
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_6353
ER  - 
@conference{
author = "Misirkić Marjanović, Maja and Vučićević, Ljubica and Kosić, Milica and Paunović, Verica and Arsikin-Csordas, Katarina and Ristić, Biljana and Marić, Nađa and Bošnjak, Mihajlo and Zogović, Nevena and Mandić, Miloš and Kravić-Stevović, Tamara and Martinović, Tamara and Ćirić, Darko and Mirčić, Aleksandar and Petričević, Saša and Bumbaširević, Vladimir and Harhaji-Trajković, Ljubica and Trajković, Vladimir",
year = "2019",
abstract = "We analyzed the impact of mitochondrial damage in anticancer action of combining lysosomal
membrane permeabilization (LMP)-inducing agent N- dodecylimidazole (NDI)[1] with
glycolytic inhibitor 2-deoxy-D-glucose (2DG) and in antipsychotic action of atypical antipsychotic
olanzapine.
NDI-triggered LMP and 2DG-mediated glycolysis block synergized in inducing ATP depletion,
mitochondrial damage and reactive oxygen species production, eventually leading to necrotic
death of U251 glioma cells but not primary astrocytes. NDI/2DG-induced death of glioma
cells was partly prevented by lysosomal cathepsin inhibitor E64 and antioxidant tocopherol, suggesting
the involvement of LMP and oxidative stress in the observed cytotoxicity. Moreover, the
combined oral administration of NDI and 2DG reduced in vivo melanoma growth in C57BL/6
mice by inducing necrotic death of tumor cells.
Based on these results, we propose that NDI-triggered LMPcauses initial mitochondrial damage
that is further increased by 2DG due to the lack of glycolytic ATP required to maintain mitochondrial
health. This leads to a positive feedback cycle of mitochondrial dysfunction, ATP loss,
and reactive oxygen species production, culminating in necrotic cell death.
We also investigated the role of autophagy, a controlled cellular self-digestion process, in regulating
survival of neurons exposed to olanzapine. Olanzapine induced autophagy in human
SH-SY5Y neuronal cell line, as confirmed by the increase in autophagic flux and presence of
autophagic vesicles, fusion of autophagosomes with lysosomes, and increase in the expression
of autophagy-related (ATG) genes ATG4B, ATG5, andATG7. The production of reactive oxygen
species, but not modulation of the main autophagy repressor mTOR or its upstream regulators
AMP-activated protein kinase and AKT1, was responsible for olanzapine-triggered autophagy.
Olanzapine-mediated oxidative stress also induced mitochondrial depolarization and damage,
and the autophagic clearance of dysfunctional mitochondria [2] was confirmed by electron microscopy,
colocalization of autophagosome associated MAP1LC3B (LC3B) and mitochondria,
and mitochondrial association with the autophagic cargo receptor p62. While olanzapine-triggered
mitochondrial damage was not visibly toxic to SH-SY5Ycells, their death was readily initiated
upon the inhibition of autophagy with pharmacological inhibitors, RNA interference knockdown
of BECN1 and LC3B. The treatment of mice with olanzapine increased the brain levels of
LC3B-II and mRNA encoding Atg4b,Atg5, Atg7, Atg12, Gabarap, and Becn1.
These data indicate that olanzapine-triggered autophagy protects neurons from otherwise fatal
mitochondrial damage, and that inhibition of autophagy might unmask the neurotoxic action
of the drug.
References;
1. Repnik U, Turk B (2010) Lysosomal-mitochondrial cross-talk during cell death.
Mitochondrion10: 662-669.
2. Wang K, Klionsky DJ(2011) Mitochondrial removal by autophagy. Autophagy 7:297-300.",
publisher = "The Mitochondrial Physiology Society",
journal = "Programme abstract book: 14th Conference on Mitochondrial Physiology: Mitochondrial function: changes during life cycle and in noncommunicable diseases: COST MitoEAGLE perspectives and MitoEAGLE WG and MC Meeting: MiP2019/MitoEAGLE; 2019 Oct 13-16; Belgrade, Serbia",
title = "Dual role of mitochondrial damage in anticancer and antipsychotic treatment",
pages = "29-29",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_6353"
}
Misirkić Marjanović, M., Vučićević, L., Kosić, M., Paunović, V., Arsikin-Csordas, K., Ristić, B., Marić, N., Bošnjak, M., Zogović, N., Mandić, M., Kravić-Stevović, T., Martinović, T., Ćirić, D., Mirčić, A., Petričević, S., Bumbaširević, V., Harhaji-Trajković, L.,& Trajković, V.. (2019). Dual role of mitochondrial damage in anticancer and antipsychotic treatment. in Programme abstract book: 14th Conference on Mitochondrial Physiology: Mitochondrial function: changes during life cycle and in noncommunicable diseases: COST MitoEAGLE perspectives and MitoEAGLE WG and MC Meeting: MiP2019/MitoEAGLE; 2019 Oct 13-16; Belgrade, Serbia
The Mitochondrial Physiology Society., 29-29.
https://hdl.handle.net/21.15107/rcub_ibiss_6353
Misirkić Marjanović M, Vučićević L, Kosić M, Paunović V, Arsikin-Csordas K, Ristić B, Marić N, Bošnjak M, Zogović N, Mandić M, Kravić-Stevović T, Martinović T, Ćirić D, Mirčić A, Petričević S, Bumbaširević V, Harhaji-Trajković L, Trajković V. Dual role of mitochondrial damage in anticancer and antipsychotic treatment. in Programme abstract book: 14th Conference on Mitochondrial Physiology: Mitochondrial function: changes during life cycle and in noncommunicable diseases: COST MitoEAGLE perspectives and MitoEAGLE WG and MC Meeting: MiP2019/MitoEAGLE; 2019 Oct 13-16; Belgrade, Serbia. 2019;:29-29.
https://hdl.handle.net/21.15107/rcub_ibiss_6353 .
Misirkić Marjanović, Maja, Vučićević, Ljubica, Kosić, Milica, Paunović, Verica, Arsikin-Csordas, Katarina, Ristić, Biljana, Marić, Nađa, Bošnjak, Mihajlo, Zogović, Nevena, Mandić, Miloš, Kravić-Stevović, Tamara, Martinović, Tamara, Ćirić, Darko, Mirčić, Aleksandar, Petričević, Saša, Bumbaširević, Vladimir, Harhaji-Trajković, Ljubica, Trajković, Vladimir, "Dual role of mitochondrial damage in anticancer and antipsychotic treatment" in Programme abstract book: 14th Conference on Mitochondrial Physiology: Mitochondrial function: changes during life cycle and in noncommunicable diseases: COST MitoEAGLE perspectives and MitoEAGLE WG and MC Meeting: MiP2019/MitoEAGLE; 2019 Oct 13-16; Belgrade, Serbia (2019):29-29,
https://hdl.handle.net/21.15107/rcub_ibiss_6353 .

Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition

Kosić, Milica; Arsikin-Csordas, Katarina; Paunović, Verica; Firestone, Raymond A; Ristić, Biljana; Mirčić, Aleksandar; Petričević, Saša; Bošnjak, Mihajlo; Zogović, Nevena; Mandić, Miloš; Bumbaširević, Vladimir; Trajković, Vladimir; Harhaji-Trajković, Ljubica

(Amsterdam: Elsevier, 2016)

TY  - JOUR
AU  - Kosić, Milica
AU  - Arsikin-Csordas, Katarina
AU  - Paunović, Verica
AU  - Firestone, Raymond A
AU  - Ristić, Biljana
AU  - Mirčić, Aleksandar
AU  - Petričević, Saša
AU  - Bošnjak, Mihajlo
AU  - Zogović, Nevena
AU  - Mandić, Miloš
AU  - Bumbaširević, Vladimir
AU  - Trajković, Vladimir
AU  - Harhaji-Trajković, Ljubica
PY  - 2016
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/6364
AB  - We investigated the in vitro and in vivo anticancer effect of combining lysosomal membrane permeabilization (LMP)-inducing agent N-dodecylimidazole (NDI) with glycolytic inhibitor 2-deoxy-D-glucose (2DG). NDI-triggered LMP and 2DG-me diated glycolysis block synergized in inducing rapid ATP
depletion, mitochondrial damage, and reactive oxygen species production, eventually leading to necrotic death of U251 glioma cells but not primary astrocytes. NDI/2DG-induced death of glioma cells was partly prevented by lysosomal cathepsin inhibitor E64 and antioxidant a-tocopherol, suggesting the involvement of LMP and oxidative stress in the observed cytotoxicity. LMP-inducing agent chloroquine also displayed a synergistic anticancer effect with 2DG, whereas glucose deprivation or glycolytic inhibitors iodoacetate and sodium fluoride synergistically cooperated with NDI, thus further indicating that the anticancer
effect of NDI/2DG combination was indeed due to LMP and glycolysis block. The two agents synergistically induced ATP depletion, mitochondrial depolarization, oxidative stress, and necrotic death also in B16 mouse melanoma cells. Moreover, the combined oral administration of NDI and 2DG reduced in vivo melanoma growth in C57BL/6 mice by inducing necrotic death of tumor cells, without causing liver, spleen, or kidney toxicity. Based on these results, we propose that NDI-triggered LMP causes initial mitochondrial damage that is further increased by 2DG due to the lack of glycolytic ATP required to maintain mitochondrial health. This leads to a positive feedback cycle of mitochondrial dysfunction, ATP loss, and reactive oxygen species production, culminating in necrotic cell death. Therefore, the combination of LMP-inducing agents and glycolysis inhibitors seems worthy of further exploration as an
anticancer strategy.
PB  - Amsterdam: Elsevier
T2  - Journal of Biological Chemistry
T1  - Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition
IS  - 44
VL  - 291
DO  - 10.1074/jbc.M116.752113
SP  - 22936
EP  - 22948
ER  - 
@article{
author = "Kosić, Milica and Arsikin-Csordas, Katarina and Paunović, Verica and Firestone, Raymond A and Ristić, Biljana and Mirčić, Aleksandar and Petričević, Saša and Bošnjak, Mihajlo and Zogović, Nevena and Mandić, Miloš and Bumbaširević, Vladimir and Trajković, Vladimir and Harhaji-Trajković, Ljubica",
year = "2016",
abstract = "We investigated the in vitro and in vivo anticancer effect of combining lysosomal membrane permeabilization (LMP)-inducing agent N-dodecylimidazole (NDI) with glycolytic inhibitor 2-deoxy-D-glucose (2DG). NDI-triggered LMP and 2DG-me diated glycolysis block synergized in inducing rapid ATP
depletion, mitochondrial damage, and reactive oxygen species production, eventually leading to necrotic death of U251 glioma cells but not primary astrocytes. NDI/2DG-induced death of glioma cells was partly prevented by lysosomal cathepsin inhibitor E64 and antioxidant a-tocopherol, suggesting the involvement of LMP and oxidative stress in the observed cytotoxicity. LMP-inducing agent chloroquine also displayed a synergistic anticancer effect with 2DG, whereas glucose deprivation or glycolytic inhibitors iodoacetate and sodium fluoride synergistically cooperated with NDI, thus further indicating that the anticancer
effect of NDI/2DG combination was indeed due to LMP and glycolysis block. The two agents synergistically induced ATP depletion, mitochondrial depolarization, oxidative stress, and necrotic death also in B16 mouse melanoma cells. Moreover, the combined oral administration of NDI and 2DG reduced in vivo melanoma growth in C57BL/6 mice by inducing necrotic death of tumor cells, without causing liver, spleen, or kidney toxicity. Based on these results, we propose that NDI-triggered LMP causes initial mitochondrial damage that is further increased by 2DG due to the lack of glycolytic ATP required to maintain mitochondrial health. This leads to a positive feedback cycle of mitochondrial dysfunction, ATP loss, and reactive oxygen species production, culminating in necrotic cell death. Therefore, the combination of LMP-inducing agents and glycolysis inhibitors seems worthy of further exploration as an
anticancer strategy.",
publisher = "Amsterdam: Elsevier",
journal = "Journal of Biological Chemistry",
title = "Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition",
number = "44",
volume = "291",
doi = "10.1074/jbc.M116.752113",
pages = "22936-22948"
}
Kosić, M., Arsikin-Csordas, K., Paunović, V., Firestone, R. A., Ristić, B., Mirčić, A., Petričević, S., Bošnjak, M., Zogović, N., Mandić, M., Bumbaširević, V., Trajković, V.,& Harhaji-Trajković, L.. (2016). Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition. in Journal of Biological Chemistry
Amsterdam: Elsevier., 291(44), 22936-22948.
https://doi.org/10.1074/jbc.M116.752113
Kosić M, Arsikin-Csordas K, Paunović V, Firestone RA, Ristić B, Mirčić A, Petričević S, Bošnjak M, Zogović N, Mandić M, Bumbaširević V, Trajković V, Harhaji-Trajković L. Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition. in Journal of Biological Chemistry. 2016;291(44):22936-22948.
doi:10.1074/jbc.M116.752113 .
Kosić, Milica, Arsikin-Csordas, Katarina, Paunović, Verica, Firestone, Raymond A, Ristić, Biljana, Mirčić, Aleksandar, Petričević, Saša, Bošnjak, Mihajlo, Zogović, Nevena, Mandić, Miloš, Bumbaširević, Vladimir, Trajković, Vladimir, Harhaji-Trajković, Ljubica, "Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition" in Journal of Biological Chemistry, 291, no. 44 (2016):22936-22948,
https://doi.org/10.1074/jbc.M116.752113 . .
14
4
13

Synergistic anticancer action of lysosomal membrane permeabilization and glycolysis inhibition

Kosić, Milica; Arsikin-Csordas, Katarina; Paunović, Verica; Firestone, Raymond A; Ristić, Biljana; Mirčić, Aleksandar; Petričević, Saša; Bošnjak, Mihajlo; Zogović, Nevena; Bumbaširević, Vladimir; Trajković, Vladimir; Harhaji-Trajković, Ljubica

(Belgrade : Serbian Society for Mitochondrial and Free-Radical Physiology, 2015)

TY  - CONF
AU  - Kosić, Milica
AU  - Arsikin-Csordas, Katarina
AU  - Paunović, Verica
AU  - Firestone, Raymond A
AU  - Ristić, Biljana
AU  - Mirčić, Aleksandar
AU  - Petričević, Saša
AU  - Bošnjak, Mihajlo
AU  - Zogović, Nevena
AU  - Bumbaširević, Vladimir
AU  - Trajković, Vladimir
AU  - Harhaji-Trajković, Ljubica
PY  - 2015
UR  - http://ssmfrp.edu.rs/article-12
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/6356
AB  - We investigated the in vitro anticancer effect of combining lysosomal membrane permeabilization (LMP)-inducing agent N-dodecylimidazole (NDI) with glycolytic inhibitor 2-deoxy-D-glucose (2DG). Cell viability was measured by MTT and LDH tests. Oxidative stress, lysosomal permeabilization, mitochondrial depolarization and apoptosis/necrosis were analyzed by flow cytometry. Cell morphology was examined by electron microscopy. Intracellular ATP content was measured by bioluminescence assay. NDI-triggered LMP and 2DG-mediated glycolysis block synergized in inducing rapid ATP depletion, mitochondrial
damage, and reactive oxygen species (ROS) production, eventually leading to necrotic death
of U251 glioma cells, but not primary astrocytes. NDI/2DG-induced death of glioma cells was
partly prevented by lysosomal cathepsin inhibitor E64 and antioxidant α-tocopherol, indicating the involvement of LMP and oxidative stress in the observed cytotoxicity. LMP-inducing agents chloroquine and NH4Cl also displayed synergistic anticancer effect with 2DG, while glycolytic inhibitors iodoacetate and sodium fluoride synergistically cooperated with NDI, thus confirming that the anticancer effect of NDI/2DG combination was indeed due to LMP and glycolysis block, respectively. Based on these results, we propose that NDI-triggered LMP causes initial mitochondrial damage that is further increased by 2DG due to the lack of glycolytic ATP required to maintain mitochondrial health. This leads to a positive
feedback cycle of mitochondrial dysfunction, ATP loss, and ROS production, culminating in necrotic cell death. Therefore, the combination of LMP-inducing agents and glycolysis inhibitors seems worthy of further exploration as an anticancer strategy.
PB  - Belgrade : Serbian Society for Mitochondrial and Free-Radical Physiology
C3  - Book of Abstracts: Third Congress Redox Medicine: Reactive Species Signaling, Analytical Methods, Phytopharmacy, Molecular Mechanisms of Disease - SSMFRP-2015; 2015 Sep 25-26; Belgrade, Serbia
T1  - Synergistic anticancer action of lysosomal membrane permeabilization and glycolysis inhibition
SP  - 71
EP  - 71
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_6356
ER  - 
@conference{
author = "Kosić, Milica and Arsikin-Csordas, Katarina and Paunović, Verica and Firestone, Raymond A and Ristić, Biljana and Mirčić, Aleksandar and Petričević, Saša and Bošnjak, Mihajlo and Zogović, Nevena and Bumbaširević, Vladimir and Trajković, Vladimir and Harhaji-Trajković, Ljubica",
year = "2015",
abstract = "We investigated the in vitro anticancer effect of combining lysosomal membrane permeabilization (LMP)-inducing agent N-dodecylimidazole (NDI) with glycolytic inhibitor 2-deoxy-D-glucose (2DG). Cell viability was measured by MTT and LDH tests. Oxidative stress, lysosomal permeabilization, mitochondrial depolarization and apoptosis/necrosis were analyzed by flow cytometry. Cell morphology was examined by electron microscopy. Intracellular ATP content was measured by bioluminescence assay. NDI-triggered LMP and 2DG-mediated glycolysis block synergized in inducing rapid ATP depletion, mitochondrial
damage, and reactive oxygen species (ROS) production, eventually leading to necrotic death
of U251 glioma cells, but not primary astrocytes. NDI/2DG-induced death of glioma cells was
partly prevented by lysosomal cathepsin inhibitor E64 and antioxidant α-tocopherol, indicating the involvement of LMP and oxidative stress in the observed cytotoxicity. LMP-inducing agents chloroquine and NH4Cl also displayed synergistic anticancer effect with 2DG, while glycolytic inhibitors iodoacetate and sodium fluoride synergistically cooperated with NDI, thus confirming that the anticancer effect of NDI/2DG combination was indeed due to LMP and glycolysis block, respectively. Based on these results, we propose that NDI-triggered LMP causes initial mitochondrial damage that is further increased by 2DG due to the lack of glycolytic ATP required to maintain mitochondrial health. This leads to a positive
feedback cycle of mitochondrial dysfunction, ATP loss, and ROS production, culminating in necrotic cell death. Therefore, the combination of LMP-inducing agents and glycolysis inhibitors seems worthy of further exploration as an anticancer strategy.",
publisher = "Belgrade : Serbian Society for Mitochondrial and Free-Radical Physiology",
journal = "Book of Abstracts: Third Congress Redox Medicine: Reactive Species Signaling, Analytical Methods, Phytopharmacy, Molecular Mechanisms of Disease - SSMFRP-2015; 2015 Sep 25-26; Belgrade, Serbia",
title = "Synergistic anticancer action of lysosomal membrane permeabilization and glycolysis inhibition",
pages = "71-71",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_6356"
}
Kosić, M., Arsikin-Csordas, K., Paunović, V., Firestone, R. A., Ristić, B., Mirčić, A., Petričević, S., Bošnjak, M., Zogović, N., Bumbaširević, V., Trajković, V.,& Harhaji-Trajković, L.. (2015). Synergistic anticancer action of lysosomal membrane permeabilization and glycolysis inhibition. in Book of Abstracts: Third Congress Redox Medicine: Reactive Species Signaling, Analytical Methods, Phytopharmacy, Molecular Mechanisms of Disease - SSMFRP-2015; 2015 Sep 25-26; Belgrade, Serbia
Belgrade : Serbian Society for Mitochondrial and Free-Radical Physiology., 71-71.
https://hdl.handle.net/21.15107/rcub_ibiss_6356
Kosić M, Arsikin-Csordas K, Paunović V, Firestone RA, Ristić B, Mirčić A, Petričević S, Bošnjak M, Zogović N, Bumbaširević V, Trajković V, Harhaji-Trajković L. Synergistic anticancer action of lysosomal membrane permeabilization and glycolysis inhibition. in Book of Abstracts: Third Congress Redox Medicine: Reactive Species Signaling, Analytical Methods, Phytopharmacy, Molecular Mechanisms of Disease - SSMFRP-2015; 2015 Sep 25-26; Belgrade, Serbia. 2015;:71-71.
https://hdl.handle.net/21.15107/rcub_ibiss_6356 .
Kosić, Milica, Arsikin-Csordas, Katarina, Paunović, Verica, Firestone, Raymond A, Ristić, Biljana, Mirčić, Aleksandar, Petričević, Saša, Bošnjak, Mihajlo, Zogović, Nevena, Bumbaširević, Vladimir, Trajković, Vladimir, Harhaji-Trajković, Ljubica, "Synergistic anticancer action of lysosomal membrane permeabilization and glycolysis inhibition" in Book of Abstracts: Third Congress Redox Medicine: Reactive Species Signaling, Analytical Methods, Phytopharmacy, Molecular Mechanisms of Disease - SSMFRP-2015; 2015 Sep 25-26; Belgrade, Serbia (2015):71-71,
https://hdl.handle.net/21.15107/rcub_ibiss_6356 .

Characterisation and preliminary lipid-lowering evaluation of Lactobacillus isolated from a traditional Serbian dairy product

Zavišić, Gordana; Ristić, Slavica; Petričević, Saša; Novaković Jovanović, Jelena; Radulović, Željka; Petković, Branka; Strahinić, Ivana; Piperski, Vesna

(Wageningen Academic Publishers, 2015)

TY  - JOUR
AU  - Zavišić, Gordana
AU  - Ristić, Slavica
AU  - Petričević, Saša
AU  - Novaković Jovanović, Jelena
AU  - Radulović, Željka
AU  - Petković, Branka
AU  - Strahinić, Ivana
AU  - Piperski, Vesna
PY  - 2015
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/2067
UR  - https://www.wageningenacademic.com/doi/abs/10.3920/BM2014.0018
AB  - We investigated the potential probiotic properties of indigenous lactic
   acid bacteria (LAB) isolated from Serbian homemade cheese. Seventeen LAB
   strains were isolated and characterised using standard protocols. One of
   the strains showed several probiotic properties: survival at low pH and
   in bile salts solution, antimicrobial activity, susceptibility to
   antibiotics and adhesion to hexodecane. DNA analysis identified the
   isolate as Lactobacillus casei, hereafter named Lactobacillus casei 5s.
   The lipid lowering effect of Lactobacillus casei 5s was evaluated in
   vivo using a hyperlipidemic rat model. Orally administered Lactobacillus
   casei 5s significantly decreased the elevated total serum cholesterol
   and triglycerides, and attenuated macro vesicular steatosis in the
   liver. Moreover, Lactobacillus casei 5s improved the intestinal
   microbial balance in favour of lactobacilli, while decreasing the number
   of Escherichia coli cells. The bacteria were re-isolated and identified
   from the surface of the intestinal mucosa and from the faecal samples of
   treated animals, indicating adhesiveness and colonisation ability. The
   results of an acute oral toxicity study in mice and the absence of
   translocation to other organs demonstrated the safety of the strain. In
   conclusion, Lactobacillus casei 5s demonstrated promising probiotic
   potential and might be a good candidate for more detailed
   investigations.
PB  - Wageningen Academic Publishers
T2  - Beneficial Microbes
T1  - Characterisation and preliminary lipid-lowering evaluation of
 Lactobacillus isolated from a traditional Serbian dairy product
IS  - 1
VL  - 6
DO  - 10.3920/BM2014.0018
SP  - 119
EP  - 128
ER  - 
@article{
author = "Zavišić, Gordana and Ristić, Slavica and Petričević, Saša and Novaković Jovanović, Jelena and Radulović, Željka and Petković, Branka and Strahinić, Ivana and Piperski, Vesna",
year = "2015",
abstract = "We investigated the potential probiotic properties of indigenous lactic
   acid bacteria (LAB) isolated from Serbian homemade cheese. Seventeen LAB
   strains were isolated and characterised using standard protocols. One of
   the strains showed several probiotic properties: survival at low pH and
   in bile salts solution, antimicrobial activity, susceptibility to
   antibiotics and adhesion to hexodecane. DNA analysis identified the
   isolate as Lactobacillus casei, hereafter named Lactobacillus casei 5s.
   The lipid lowering effect of Lactobacillus casei 5s was evaluated in
   vivo using a hyperlipidemic rat model. Orally administered Lactobacillus
   casei 5s significantly decreased the elevated total serum cholesterol
   and triglycerides, and attenuated macro vesicular steatosis in the
   liver. Moreover, Lactobacillus casei 5s improved the intestinal
   microbial balance in favour of lactobacilli, while decreasing the number
   of Escherichia coli cells. The bacteria were re-isolated and identified
   from the surface of the intestinal mucosa and from the faecal samples of
   treated animals, indicating adhesiveness and colonisation ability. The
   results of an acute oral toxicity study in mice and the absence of
   translocation to other organs demonstrated the safety of the strain. In
   conclusion, Lactobacillus casei 5s demonstrated promising probiotic
   potential and might be a good candidate for more detailed
   investigations.",
publisher = "Wageningen Academic Publishers",
journal = "Beneficial Microbes",
title = "Characterisation and preliminary lipid-lowering evaluation of
 Lactobacillus isolated from a traditional Serbian dairy product",
number = "1",
volume = "6",
doi = "10.3920/BM2014.0018",
pages = "119-128"
}
Zavišić, G., Ristić, S., Petričević, S., Novaković Jovanović, J., Radulović, Ž., Petković, B., Strahinić, I.,& Piperski, V.. (2015). Characterisation and preliminary lipid-lowering evaluation of
 Lactobacillus isolated from a traditional Serbian dairy product. in Beneficial Microbes
Wageningen Academic Publishers., 6(1), 119-128.
https://doi.org/10.3920/BM2014.0018
Zavišić G, Ristić S, Petričević S, Novaković Jovanović J, Radulović Ž, Petković B, Strahinić I, Piperski V. Characterisation and preliminary lipid-lowering evaluation of
 Lactobacillus isolated from a traditional Serbian dairy product. in Beneficial Microbes. 2015;6(1):119-128.
doi:10.3920/BM2014.0018 .
Zavišić, Gordana, Ristić, Slavica, Petričević, Saša, Novaković Jovanović, Jelena, Radulović, Željka, Petković, Branka, Strahinić, Ivana, Piperski, Vesna, "Characterisation and preliminary lipid-lowering evaluation of
 Lactobacillus isolated from a traditional Serbian dairy product" in Beneficial Microbes, 6, no. 1 (2015):119-128,
https://doi.org/10.3920/BM2014.0018 . .
4
1
2